Takeda presents new data showing mezagitamab sustained effect on kidney function 18 months after treatment in primary IgA nephropathy: Osaka, Japan Monday, November 10, 2025, 15:0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback